Účinnost xx 31.3.2006 xx 22.9.2007 (xx xxxxxx x. 230/2007 Xx.)
Xxxxxxx x. 6 x vyhlášce x. 26/2001 Xx.
Xxxx 1
Xxxxxx xxxxxxxxxxxxx xxxxxx xxxxxxxxxx x xxxxxxxxxxxx xxxxxxxxxxxx, xxxxxxxx xxxxxxxxx koncentrace, xxxxxxxxx xx čistotu xxxxxxxxx xxxxxxxxxxxxx xxxxxx x xxxxxxxx xxxxxxx
Xx xxxxxxxxxxx přísady se xxxxxxxx x soli xxxxx, xxxxxxxxx v xxxxxxx x. 6. x xx xxxx xxxxxxxx, sodné, xxxxxxxx, xxxxxxxxx, amonné, xxxxxxxxxxxxxx x xxxx xxxxxxxx, xxxxxxx, xxxxxx, xxxxxx x xxxxxx-, ethyl-, xxxxxx, xxxxxxxxx-, butyl-, xxxxxxxx- a xxxxxxxxxxx.
Xxxxx xxxxxxxx symbolem (+) xxx xxxxxxxx xx xxxxxxxxxxxx xxxxxxxxxx rovněž x xxxxxxxxxxx jiné, xxx xx x xxxxxxx x. 6 xxxxxxx, ale jen xxx specifické xxxxx, xxxxx xxxx xxxxxx x xxxxxxxxxxx xxxxxx, xxxxxxxx xxxxx xxxxxxx xxxxxxxxxxxx prostředku, například xxxx dezodoranty do xxxxx xxxx xxxxxxx xxxxx lupům xx xxxxxxx.
Xxxxxxx xxxxx xxxxxxxxx xx xxxxxxxxx xxxxxxxxxxxx xxxxxxxxxx mohou mít xxxxxx xxxxxxxxxxxxxxx xxxxxxxxxx x xxxxx xxx xxxxxxxxx xxxxxxxxxx xxxxxxx. Xxx například x xxxx éterických xxxxx x některé xxxxxxxx. Xxxx xxxxx xxxxxx xxxxxxxx xx přílohy x. 6.
Xxxxxxx xxxxxxx xxxxxxxxxx xxxxxxxxxx, xxxxx xxxxxxxx xxxxxxxxxxx nebo xxxxx xxxxxxxxxxx xxxxxxxxxx, xxxx xxx xx xxxxx označeny xxxxxxxxx "xxxxxxxx xxxxxxxxxxx", xxxxx xxxxxxxxxxx xxxxxxxxxxxx xx xxxxxxxx xxxxxxx překročí 0,05 xxxxxxx.
___________________________________________________________________________________________
Xxx. Xxxxx Xxxxxxxxx Xxxxxxx x xxxxxxxxx Xxxxxxxx xxxxxxx
xxxxx xxxxxxxx koncentrace a xxxxxxxx, která musí
být xxxxxxxxx na xxxxx
___________________________________________________________________________________________
x x x x e
___________________________________________________________________________________________
1 Xxxxxxxx xxxxxxxx•; 0,5 % v přepočtu xx xxxxxxxx
/Xxxxxxx acid/°, xxxx xxxx
x estery (+)
___________________________________________________________________________________________
2 Xxxxxxxx xxxxxxxxxx•; 2 % v xxxxxxxx xx xxxxxxxx
/Xxxxxxxxx acid/°a xxxx soli
___________________________________________________________________________________________
3 Xxxxxxxx xxxxxxxxxx•; 0,5 % x xxxxxxxx na xxxxxxxx Xxxxx xxx xxxxxxx xx xxxxxxx xxx Xxxxxxxxxx pro xxxx
/Xxxxxxxxx acid /°x xxxx xxxx do 3 xxx x xxxxxxxx xxxxxxx. xx 3 xxx (1).
soli (+)
___________________________________________________________________________________________
4 Kyselina xxxxxxx (hexa- 0,6 % x přepočtu na xxxxxxxx
-2,4-xxxxxxx xxxxxxxx)•;
/Xxxxxx xxxx (xxxx-2,4-
-xxxxxxx xxxx)/°x xxxx
xxxx (+)
___________________________________________________________________________________________
5 Xxxxxxxxxxx•; 0,2 % (xxxx prostředky xxx Xxxxxxxx x xxxxxxxxxxxxxx
/Xxxxxxxxxxxx/°x xxxxxxx úst) aerosolů (xxxxxxxx).
xxxxxxxxxxxxxxx• ; 0,1 % (xxxxxxxxxx xxx xxxxxxx
/Xxxxxxxxxxxxxxxx/°(+) xxx) x přepočtu xx xxxxx
xxxxxxxxxxx
___________________________________________________________________________________________
6 xxxxxxx xxxxxxxxxx
___________________________________________________________________________________________
7 Xxxxxxx.-2-xx(x-xxxxx- 0,2 % x xxxxxxxx na xxxxx
xxxxx)•; /Xxxxxxxx-2-
-xx(x-xxxxxxxxxxxx/°)
x xxxx xxxx (+)
___________________________________________________________________________________________
8 Xxxxxxxxx zinečnatý• 0,5 % Povolen xxx xxx prostředky,
/Pyrithione xxxx/* (+) xxxxx se xxxxxxxxx. Zakázán
v xxxxxxxxxxxx xxxxx xxxxxxx.
___________________________________________________________________________________________
9 Xxxxxxxxxxx xxxxxxxxxx 0,2 % x xxxxxxxx xx volný XX2
x xxxxxxxxxxxxxxxxxx
/Xxxxxxxxx sulphites xxx
xxxxxxxxxxxxxxxxx/°(+)
___________________________________________________________________________________________
10 Xxxxxxxx sodný 0,1 % Xxx xxx xxxxxxxxxx, xxxxx
/Xxxxxx xxxxxx/° xx xxxxxxxxx.
___________________________________________________________________________________________
11 Chlorbutanol• 0,5 % Zakázáno v xxxxxxxxxxxxxx Xxxxxxxx
/Xxxxxxxxxxxx/* xxxxxxxx (xxxxxxxx). xxxxxxxxxxxx.
___________________________________________________________________________________________
12 Xxxxxxxx 4- 0,4 % jako xxxxxxxx xxx xxxxx
-xxxxxxxxxxxxxxx•; xxxxx
/4-Xxxxxxxxxxxxxx 0,8 % jako xxxxxxxx xxx směs
acid/°a xxxx xxxx x xxxxxx
xxxxxx (+)
___________________________________________________________________________________________
13 3-Acetyl-6-methyl-2,3- 0,6 % x xxxxxxxx xx kyselinu Zakázáno v xxxxxxxxxxxxxx
-xxxxxxx-4X-xxxxx-2,4- xxxxxxxx (xxxxxxxx).
-xxxx•; /Acetyl-6-methyl-
-pyran-2,4(3H)-dione
(Dehydroacetic xxxx)/°
x xxxx xxxx
___________________________________________________________________________________________
14 Kyselina xxxxxxxx•; 0,5 x xxxxxxxx na xxxxxxxx
/Xxxxxx xxxx/°x xxxx
xxxxx sůl/ (+)
___________________________________________________________________________________________
15 3,3´-Xxxxxx-4,4´- 0,1%
(xxxxx-1,6-xxxxxxxxx)
xxxxxxxxxxxxxx•
(Xxxxxxxxxxxxxxx);
/3,3´-Xxxxxxx-4,4´-
-xxxxxxxxxxxxxxxxxx-
xxxxxxxxxxxxx
(Xxxxxxxxxxxxxxxx/°
x jeho soli xxxxxx
xxxxxxxxxxx•
/xxxxxxxxxxx/°(2-xxxxx-
xxxxxxx-1-xxxxxxxxx)•
___________________________________________________________________________________________
16 Xxxxxxxxxx• /Thiomersal/* 0,007 % (xxxx Xx) xx xxxxx x Pouze xxx xxxxxxxxxx x xxxxxx Xxxxxxxx thiomersal.
ostatními xxxxxxxxxxxx xxxxx x xxxxxxxxxx xxx.
xxxxxxxxxx xxxxx xxxxxxxxx
xxxxxxx xxxxxxxxx xxxxxxxx
xxxxxxxxxxx 0,007 % Xx
___________________________________________________________________________________________
17 Xxxxxxxxxxxxx soli• 0,007 % (xxxx Xx) xx směsi s Xxxxx xxx prostředky x xxxxxx Xxxxxxxx
(xxxxxx xxxxxx) xxxxxxxxx xxxxxxxxxxxx xxxxx x xxxxxxxxxx xxxxx očí. fenylrtuťnaté
/Phenylmercuric xxxxx xxxxxxxxxx xxxxx xxxxxxxxx xxxxxxxxxx.
(xxxxxxxxx xxxxxx)/° xxxxxxx xxxxxxxxx xxxxxxxx
xxxxxxxxxxx 0,007 % x Xx
___________________________________________________________________________________________
18 Xxxxxxxx xxxx-10-xxxxx•; 0,2 % x xxxxxxxx xx xxxxxxxx
/Xxxxx-10-xxxxx xxxx/°
x její soli(+)
___________________________________________________________________________________________
19 Hexetidin 0,1 %
/Xxxxxxxxxx/* (+)
___________________________________________________________________________________________
20 5-xxxx-5-xxxxx-1,3-xxxxxx 0,1 % Xxx xx xxxxxxxxxx, xxxxx xx
(Xxxxxxxx)• /5-Xxxxx-5- xxxxxxxxx.
-xxxxx-1,3-xxxxxxx/° Xxxxxxx xxxxxx xxxxxxxxxxx.
___________________________________________________________________________________________
21 Xxxxxxxx /Xxxxxxxx/* (+) 0,1 % Xxxxxxx tvorbě xxxxxxxxxxx.
___________________________________________________________________________________________
22 2,4-Xxxxxxx-xxxxxx- 0,15 %
xxxxxxx• /2,4-Dichloro-
benzyl xxxxxxx/°(+)
___________________________________________________________________________________________
23 Xxxxxxxxxxxx 0,2 % Xxxxxxxx xxxxxxx: 3,3´,4,4´-
/Triclocarban/* (+) xxxxxxxxxxxxxxxxxxx xxxx než 1
xxx 3,3´,4,4´-tetrachlorazoxy-
benzen xxxx než 1 xxx
___________________________________________________________________________________________
24 4-Xxxxx-x-xxxxxx• 0,2% Xxxxxxx v xxxxxxxxxxxx
/4-Xxxxxx-x-xxxxxx/°(+) xxxxxxxxxxxxxx xx kontaktu
se xxxxxxxx.
___________________________________________________________________________________________
25. Xxxxxxxxx /Xxxxxxxxx/* (+) 0,3 %
___________________________________________________________________________________________
26 4-Xxxxx-3,5-xxxxxxx(4- 0,5 %
-chlor-3,5-dimethylfenol)•
/4-Chloro-3,5-xylenol/°(+)
___________________________________________________________________________________________
27 3,3´-Xxx[1-(xxxxxxx- 0,6 %
methyl)-2,5-dioxoimida-
zolidin-4-yl]-1,1´-
methylendimočovina
(imidazolidinylmočovina)•
/3,3´--Bis(1-hydroxy-
methyl-2,5-dioxoimida-
zolidin-4-yl)-1,1´-methyl-
ene-iurea ("Xxxxxxxxxxxxxx
xxxx") /°(+)
___________________________________________________________________________________________
28 Xxxx-1-xxxxxxxxxxxx 0,3 %
xxxxxxxx-xxxxxxxxxxxx•
/Xxxx-(1-xxxxxxxxxx-
xxxxxxxxxxx xxxxx-
xxxxxxxx/°(+)
___________________________________________________________________________________________
29 2-Xxxxxxxxxxx-1-xx• 1 %
/2-Xxxxxxxxxxxxxx/°(+)
___________________________________________________________________________________________
30 Hexamethylentetramin 0,15 %
(xxxxxxxxxx, urotropin)•
/Hexamethylentetramine
(methenamine*)/°(+)
___________________________________________________________________________________________
31 Xxxxxxxxxx-3-xxxxxx- 0,2 %
-xxxxxxxxxxxx•
/Xxxxxxxxxxx-3-xxxxxx-
xxxxxxxxxxxxx/°(XXXX)
___________________________________________________________________________________________
32 1-(4-Xxxxxxxxxxx)-1- 0,5 %
(xxxxxxxx-1-xx)-3,3´-
xxxxxxxxxxxxx-2-xx•
/1-(4-Xxxxxxxxxxxxx)-
-1-(xxxxxxxx-1-xx)3,3-
-xxxxxxxxxxxxx-2xxx/°
(+)
___________________________________________________________________________________________
33 1,3-Bis(hydroxymethyl)- 0,6 %
-5,5-xxxxxxxxxxxxxxxxxxxx-
2,4-xxxx• /1,3-Xxx
(xxxxxxx-xxxxxx)-5,5-
-xxxxxxxx-xxxxxxxxxxxxx-
-2,4-xxxxx/°(+)
___________________________________________________________________________________________
34 Xxxxxxxxxxxxx• 1 %
/Xxxxxx xxxxxxx/°
___________________________________________________________________________________________
35 1-Xxxxxxx-4-xxxxxx-6- 1 % Xxx xxxxxxxxxx, které se xxxxxxxxx.
(2,4,4-xxxxxxxxxxxxxxx)
xxxxxxx-2(1X)-xx•;
/1-Xxxxxxx-4-xxxxxx-6 0,5 % Xxx xxxxxxx xxxxxxxxxx.
(2,4,4-xxxxxxxxx-xxxxxx)
2-xxxxxxx/°x xxxx
xxxxxxx x xxxxxxxxxx-
xxxxxxx• (xxxxxxxxx) (+)
___________________________________________________________________________________________
36 1,2-Xxxxxx-2,4- 0,1 % Xxxxx xxx prostředky, xxxxx
xxxxxxxxxxx• se oplachují.
/1,2-Dibromo-2,4-
-dicyanobutane°
METHYLDIBROMO
GLUTARONITRILE•
___________________________________________________________________________________________
37 6,6´-Xxxxxx-4,4-´xxxxxxx- 0,1 %
-2,2-´xxxxxxxxxxxxxxx•
(Xxxxxxxxxxxxxx)
/6,6-Xxxxxxx-4,4-xxxxxxxx-
2,2-´xxxxxxxxxxxxxxxxx
(Xxxxxxxxxxxxxxx)/°(+)
___________________________________________________________________________________________
38 4-Xxxxxxxxx-x-xxxxxx 0,1 %
(4-isopropyl-3-methylfenol)•
/4-Isopropyl-m-cresol/°
___________________________________________________________________________________________
39 Xxxx 5-xxxxx-2-xxxxxx- 0,0015 % (Xxxx v xxxxxx 3 :1
-isothiazol-3(2H)-onu• 5-xxxxx-2-xxxxxx-xxxxxxxxxx-3(2X)-
/5-xxxxxx-2-xxxxxxx- -xx a 2-xxxxxxxxxxxxxxxx-3(2X)-xx
xxxxxxxxx-3(2X)-xxx/°x
2-xxxxxxxxxxxxxxxx-3(2X)-
-xxx• /2-xxxxxxxxxxxxxxxx-
3(2X)-xxx/°x xxxxxxxxx
xxxxxxxxxx /xxxxxxxxx
xxxxxxxx/°x xxxxxxxxxx
xxxxxxxxxx /xxxxxxxxx
xxxxxxx/°
___________________________________________________________________________________________
40 2-Benzyl-4-chlorfenol• 0,2 %
(Xxxxxxxxx) /2-Xxxxxx-4-
-xxxxxxxxxxx
(Xxxxxxxxxxx)/°
___________________________________________________________________________________________
41 Xxxxxxxxxxxxx• 0,3 % Xxxxxxxx
/2-Xxxxxxxxxxxxxx/° xxxxxxxxxxxxx.
___________________________________________________________________________________________
42 Chlorhexidin• 0,3 % x xxxxxxxx na xxxxxxxxxxxx
/Xxxxxxxxxxxxx/* x jeho
diglukonát, /xxxxxxxxxxx/°,
xxxxxxxx /xxxxxxxxx/ x
xxxxxxxxxxxxxx
/xxxxxxxxxxxxxxx/°(+)
___________________________________________________________________________________________
43 1-Xxxxxxxxxxxx-2-xx• 1,0 % Xxx xxx prostředky, xxxxx xx
/1-Xxxxxxxxxxxxx-2-xx/° xxxxxxxxx.
___________________________________________________________________________________________
44 Xxxxx (X12 - C22) 0,1 %
xxxxxxxxxxxxxxxxxxxxxx
x -chlorid•
/Alkyl (X12 - X22) xxxxxxxxx
xxxxxxxx-xxxxxxx
x xxxxxxxx/°(+)
___________________________________________________________________________________________
45 4,4-Xxxxxxxx-1,3- 0,1 % pH konečného xxxxxxxx xxxxx
-xxxxxxxxxx• /4,4-Xx- xxx xxxxx než 6.
methyl-1,3-oxazolidine/
___________________________________________________________________________________________
46 1-[1,3-Xxx(xxxxxxx- 0,5 %
-xxxxxx)-2,5-xxxxx-
xxxxxxxxxxxx-4-xx]-1,3-
-xxx(xxxxxxxxxxxxx)
xxxxxxxx•
/X-(Xxxxxxxxxxxxx)-X-
-(xxxxxxxxxxxxxxx-1,3-
-xxxxx-2,5-xxxxxxxxxxx-
xxx-4)X´-(xxxxxxx-
xxxxxx)xxxx/
___________________________________________________________________________________________
47 4,4-´(Xxxxx-1,6-xxxxxx- 0,1 %
xxx)xxxxxxxxxxxxxx•
/1,6-Xx(4-xxxxxxxxxxxx-
xx)-x-xxxxxx(Xxxxxxxx-
xx)/°x jeho soli xxxxxx
xxxxxxxxxxx (2-xxxxxxx-
-xxxxx-1-xxxxxxxxx)•
/xxxxxxxxxxx/°x 4-xxxxx-
xxxxxxxxxx• /x-xxxxx-
xxxxxxxxxx/°(+)
___________________________________________________________________________________________
48 Xxxxxxxxxxxxxx 0,1 % Xxxxxxxx x rozprašovačích Obsahuje
(pentandial)• xxxxxxxx (xxxxxxxx). xxxxxxxxxxxxx.
/Xxxxxxxxxxxxx (při xxxxxx
(Xxxxxxx-1,5-xxxx)/° glutaraldehydu x
xxxxxxxx xxxxxxxx
xxxxxx xxx 0,05 %)
___________________________________________________________________________________________
49 5-Ethyl-3,7-dioxa-1- 0,3 % Xxxxxxx x xxxxxxxxxxxx xxxxx
-xxxxxxxxxx[3.3.0]xxxxx• xxxxxxx x x xxxxxxxxxxxx
/5-Xxxxx-3,7-xxxxx-1- xxxxxxxxxxxxxx do xxxxxxxx
-xxxxxxxxxx[3.3.0] xx xxxxxxxx.
xxxxxx/°
___________________________________________________________________________________________
50 3-(4-Xxxxxxxxxxx)-xxxxxx- 0,3 %
-1,2xxxx• (Xxxxxxxxxxxx)
/3-(x-Xxxxxxxxxxxx)-
-xxxxxxx-1,2-xxxx
(Xxxxxxxxxxxxx)/°
___________________________________________________________________________________________
51 [(Xxxxxxxxxxxxx)xxxxx] 0,5 %
xxxxxx xxxxx, X-(xxxxxxx-
xxxxxx)-xxxxxxxx xxxxx,•
/Xxxxxx xxxxxxxxxxxxxx-
xxxxxxxxxxx, (Xxxxxx
xxxxxxxxxxxxxxxxxxxxxx)/°
___________________________________________________________________________________________
52 Xxxxxxx stříbrný zakot- 0,004 % v přepočtu xx XxXx 20 % (xxxxx.)XxXx xx XxX2
xxxx xx oxidu xxxxxxxxxxx Xxxxxxx x xxxxxxxxxxxx xxx xxxx xx
/Xxxxxx xxxxxxxx xxxxxxxxx 3 let, x xxxxxxxxxxxx ústní hygieny
on Xxxxxxxx xxxxxxx/° x v xxxxxxxxxxxx aplikovaných xx
xxxxx xxx x na xxx.
___________________________________________________________________________________________
53 Xxxxxx{2-[2-(xxxxxxxxxxxx- 0,1 % x) xxxxxxxxxx, které xx xxxxxxxxx;
xxxx)xxxxxx]xxxxx}xx- x) xxxxxxxxx, xxxxx zůstávají xx xxxx, xxxxx prostředků
methylamonium-chlorid xxx xxxx x xxxxxx xxxxx
Xxxxxxxxxxxx-xxxxxxx•
XXXXXXXXXXXX XXXXXXXX°
___________________________________________________________________________________________
54 Alkyl(C8 - X18) (benzyl) 0,1 % x přepočtu xx Xxxxxxx styku x očima.
dimethylamonium-chlorid, benzalkonium-chlorid
-bromid a xxx s xxxxxxxx
xxxxxxxxx (xxxxxxxxxxxx
-xxxxxxx, -xxxxxx a xxx s
cukernou kyselinou)•
/Benzalkonium xxxxxxxx,
xxxxxxx xxx
xxxxxxxxxxxx/°(+)
___________________________________________________________________________________________
55 Benzylhemiformal 0,15 % Xxx xxx xxxxxxx, xxxxx xx
(xxxxxxxxxxxxxxxxx)• odstraňují xxxxxxxxxxxx.
/Xxxxxxxxxxxxxxxx/°
___________________________________________________________________________________________
56 3-Xxxxxxx-2-xx-1-xx-X- 0,05 % 1. Xxxxx xx xxxxxxxx x Xxxxxxxx xxx.
-xxxxxxxxxxxxx• xxxxxxxxxxxx xxxxx hygieny x x
/3-Xxxx-2-xxxxxxxx-xxxxx- xxxxxxxxxxxx k xxxx x rty.
carbamate/° 2. Pokud xxxxxxxxxxx x
xxxxxxxxxxxx, xxxxx xxxx xxxxxx
x xxxx, xxx xxxxxxxxx xx
xxxxxxx, xxxxxxxx 0,02 %,
xxxxxxxx xxxx: Xxxxxxxx xxx.
___________________________________________________________________________________________
57 2-xxxxxxxxxxxxxxxx- 0,01 %
-3(2X)-xx•
XXXXXXXXXXXXXXX-
XXXXXX°
___________________________________________________________________________________________
(1) Xxxxx pouze xxx výrobky, které xx mohly být xxxxxxx pro xxxx xx 3 let x které zůstávají x xxxxxxxxxxxx xxxxxxxx x xxxx.
(*) X xxxx xxxxxxx je xxxxx xxxxxxxx xxxxxxx xxxxx xxxxxxxxxxx x xxxxxxx xxxxxxxxxxx xxxxxxxxxxxx xxxxx xxx xxxxxxxxxxxxx xxxxxxx "Xxxxxxxx print-out 1975, Xxxxxxxxxxxxx Non-proprietary Xxxxx (XXX) xxx xxxxxxxxxxxxxx products Lists 1,33 of proposed XXX", XXX, Xxxxxx, Xxxxxx 1975.
(•) X xxxx příloze je xxxxx xxxxxxxx xxxxxxx xxxxx xxxxxxxxx xxxxx "Xxxxxxxx xxxxxxxxxxx xxxxxxxxxxx xxxxxxxxx xxxxx XXXXX (Xxxxxxxxxx 1993)", Xxxxxxxx, Xxxxx 2000.
(°) X xxxx xxxxxxx xx xxxxx způsobem xxxxxxx xxxxx x xxxxxxxxx xxxxxx, xxxxxxxx x xxxxxxxxx "Xxx Cosmetics Xxxxxxxxx 76/768/XXX", Colipa, Xxxxxxxx, March 2000.
Xxxx 2
Xxxxxx xxxxxxxxxxxxx xxxxxx xxxxxxx povolených v xxxxxxxxxxxx xxxxxxxxxxxx, nejvyšší xxxxxxxxx koncentrace, xxxxxxxxx xx xxxxxxx vybraných xxxxxxxxxxxxx xxxxxx x xxxxxxxx xxxxxxx
_______________________________________________________________________________________
Xxx. číslo Látka Maximální Xxxxxxx x Xxxxxxxx xxxxxxx x xxxxxxxx,
xxxxxxxx xxxxxxxxx xxxxx xxxx xxx xxxxxxxxx xx
xxxxxxxxxxx xxxxx
_______________________________________________________________________________________
x x x x x
_______________________________________________________________________________________
_______________________________________________________________________________________
_______________________________________________________________________________________
Xxxxxxxx: X xxxxxxxx době tato xxxxxxx neobsahuje žádnou xxxxx.